Report Detail
COVID-19 Impact on Global NSAIDs, Market Insights and Forecast to 2026
- RnM4084349 |
- 30 June, 2020 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
NSAIDs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NSAIDs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the NSAIDs market is segmented into
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application, the NSAIDs market is segmented into
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Regional and Country-level Analysis
The NSAIDs market is analysed and market size information is provided by regions (countries).
The key regions covered in the NSAIDs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and NSAIDs Market Share Analysis
NSAIDs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NSAIDs business, the date to enter into the NSAIDs market, NSAIDs product introduction, recent developments, etc.
The major vendors covered:
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
1 Study Coverage
- 1.1 NSAIDs Product Introduction
- 1.2 Market Segments
- 1.3 Key NSAIDs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global NSAIDs Market Size Growth Rate by Type
- 1.4.2 Aspirin
- 1.4.3 Ibuprofen
- 1.4.4 Naproxen
- 1.4.5 Nabumetone
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global NSAIDs Market Size Growth Rate by Application
- 1.5.2 Back Pain Treatment
- 1.5.3 Osteoarthritis Treatment
- 1.5.4 Other Disease Treatment
- 1.6 Coronavirus Disease 2019 (Covid-19): NSAIDs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the NSAIDs Industry
- 1.6.1.1 NSAIDs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and NSAIDs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for NSAIDs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the NSAIDs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global NSAIDs Market Size Estimates and Forecasts
- 2.1.1 Global NSAIDs Revenue 2015-2026
- 2.1.2 Global NSAIDs Sales 2015-2026
- 2.2 NSAIDs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global NSAIDs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global NSAIDs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global NSAIDs Competitor Landscape by Players
- 3.1 NSAIDs Sales by Manufacturers
- 3.1.1 NSAIDs Sales by Manufacturers (2015-2020)
- 3.1.2 NSAIDs Sales Market Share by Manufacturers (2015-2020)
- 3.2 NSAIDs Revenue by Manufacturers
- 3.2.1 NSAIDs Revenue by Manufacturers (2015-2020)
- 3.2.2 NSAIDs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global NSAIDs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by NSAIDs Revenue in 2019
- 3.2.5 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 NSAIDs Price by Manufacturers
- 3.4 NSAIDs Manufacturing Base Distribution, Product Types
- 3.4.1 NSAIDs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers NSAIDs Product Type
- 3.4.3 Date of International Manufacturers Enter into NSAIDs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global NSAIDs Market Size by Type (2015-2020)
- 4.1.1 Global NSAIDs Sales by Type (2015-2020)
- 4.1.2 Global NSAIDs Revenue by Type (2015-2020)
- 4.1.3 NSAIDs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global NSAIDs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global NSAIDs Sales Forecast by Type (2021-2026)
- 4.2.2 Global NSAIDs Revenue Forecast by Type (2021-2026)
- 4.2.3 NSAIDs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global NSAIDs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global NSAIDs Market Size by Application (2015-2020)
- 5.1.1 Global NSAIDs Sales by Application (2015-2020)
- 5.1.2 Global NSAIDs Revenue by Application (2015-2020)
- 5.1.3 NSAIDs Price by Application (2015-2020)
- 5.2 NSAIDs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global NSAIDs Sales Forecast by Application (2021-2026)
- 5.2.2 Global NSAIDs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global NSAIDs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America NSAIDs by Country
- 6.1.1 North America NSAIDs Sales by Country
- 6.1.2 North America NSAIDs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America NSAIDs Market Facts & Figures by Type
- 6.3 North America NSAIDs Market Facts & Figures by Application
7 Europe
- 7.1 Europe NSAIDs by Country
- 7.1.1 Europe NSAIDs Sales by Country
- 7.1.2 Europe NSAIDs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe NSAIDs Market Facts & Figures by Type
- 7.3 Europe NSAIDs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific NSAIDs by Region
- 8.1.1 Asia Pacific NSAIDs Sales by Region
- 8.1.2 Asia Pacific NSAIDs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific NSAIDs Market Facts & Figures by Type
- 8.3 Asia Pacific NSAIDs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America NSAIDs by Country
- 9.1.1 Latin America NSAIDs Sales by Country
- 9.1.2 Latin America NSAIDs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America NSAIDs Market Facts & Figures by Type
- 9.3 Central & South America NSAIDs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa NSAIDs by Country
- 10.1.1 Middle East and Africa NSAIDs Sales by Country
- 10.1.2 Middle East and Africa NSAIDs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa NSAIDs Market Facts & Figures by Type
- 10.3 Middle East and Africa NSAIDs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Corporation Information
- 11.1.2 Bayer Description, Business Overview and Total Revenue
- 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer NSAIDs Products Offered
- 11.1.5 Bayer Recent Development
- 11.2 Novacap
- 11.2.1 Novacap Corporation Information
- 11.2.2 Novacap Description, Business Overview and Total Revenue
- 11.2.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Novacap NSAIDs Products Offered
- 11.2.5 Novacap Recent Development
- 11.3 Abbott
- 11.3.1 Abbott Corporation Information
- 11.3.2 Abbott Description, Business Overview and Total Revenue
- 11.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Abbott NSAIDs Products Offered
- 11.3.5 Abbott Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Corporation Information
- 11.4.2 Pfizer Description, Business Overview and Total Revenue
- 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Pfizer NSAIDs Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Corporation Information
- 11.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
- 11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Johnson & Johnson NSAIDs Products Offered
- 11.5.5 Johnson & Johnson Recent Development
- 11.6 Cigna
- 11.6.1 Cigna Corporation Information
- 11.6.2 Cigna Description, Business Overview and Total Revenue
- 11.6.3 Cigna Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Cigna NSAIDs Products Offered
- 11.6.5 Cigna Recent Development
- 11.7 Geri-Care Pharmaceuticals
- 11.7.1 Geri-Care Pharmaceuticals Corporation Information
- 11.7.2 Geri-Care Pharmaceuticals Description, Business Overview and Total Revenue
- 11.7.3 Geri-Care Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
- 11.7.5 Geri-Care Pharmaceuticals Recent Development
- 11.8 Perrigo Company
- 11.8.1 Perrigo Company Corporation Information
- 11.8.2 Perrigo Company Description, Business Overview and Total Revenue
- 11.8.3 Perrigo Company Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Perrigo Company NSAIDs Products Offered
- 11.8.5 Perrigo Company Recent Development
- 11.9 Kopran
- 11.9.1 Kopran Corporation Information
- 11.9.2 Kopran Description, Business Overview and Total Revenue
- 11.9.3 Kopran Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Kopran NSAIDs Products Offered
- 11.9.5 Kopran Recent Development
- 11.10 Merck Sharp & Dohme
- 11.10.1 Merck Sharp & Dohme Corporation Information
- 11.10.2 Merck Sharp & Dohme Description, Business Overview and Total Revenue
- 11.10.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Merck Sharp & Dohme NSAIDs Products Offered
- 11.10.5 Merck Sharp & Dohme Recent Development
- 11.1 Bayer
- 11.1.1 Bayer Corporation Information
- 11.1.2 Bayer Description, Business Overview and Total Revenue
- 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer NSAIDs Products Offered
- 11.1.5 Bayer Recent Development
- 11.12 GlaxoSmithKline
- 11.12.1 GlaxoSmithKline Corporation Information
- 11.12.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.12.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 GlaxoSmithKline Products Offered
- 11.12.5 GlaxoSmithKline Recent Development
- 11.13 Reddy Pharmaceuticals
- 11.13.1 Reddy Pharmaceuticals Corporation Information
- 11.13.2 Reddy Pharmaceuticals Description, Business Overview and Total Revenue
- 11.13.3 Reddy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Reddy Pharmaceuticals Products Offered
- 11.13.5 Reddy Pharmaceuticals Recent Development
- 11.14 Verywell
- 11.14.1 Verywell Corporation Information
- 11.14.2 Verywell Description, Business Overview and Total Revenue
- 11.14.3 Verywell Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Verywell Products Offered
- 11.14.5 Verywell Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 NSAIDs Market Estimates and Projections by Region
- 12.1.1 Global NSAIDs Sales Forecast by Regions 2021-2026
- 12.1.2 Global NSAIDs Revenue Forecast by Regions 2021-2026
- 12.2 North America NSAIDs Market Size Forecast (2021-2026)
- 12.2.1 North America: NSAIDs Sales Forecast (2021-2026)
- 12.2.2 North America: NSAIDs Revenue Forecast (2021-2026)
- 12.2.3 North America: NSAIDs Market Size Forecast by Country (2021-2026)
- 12.3 Europe NSAIDs Market Size Forecast (2021-2026)
- 12.3.1 Europe: NSAIDs Sales Forecast (2021-2026)
- 12.3.2 Europe: NSAIDs Revenue Forecast (2021-2026)
- 12.3.3 Europe: NSAIDs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific NSAIDs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: NSAIDs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: NSAIDs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: NSAIDs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America NSAIDs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: NSAIDs Sales Forecast (2021-2026)
- 12.5.2 Latin America: NSAIDs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: NSAIDs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa NSAIDs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: NSAIDs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: NSAIDs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: NSAIDs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key NSAIDs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 NSAIDs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global NSAIDs. Industry analysis & Market Report on COVID-19 Impact on Global NSAIDs is a syndicated market report, published as COVID-19 Impact on Global NSAIDs, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global NSAIDs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
